ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

No reported Depreciation & Amortization figures are available to summarize.

Depreciation & Amortization history

Currency unavailable · from the income statement

No Depreciation & Amortization data reported for this period type.

Depreciation & Amortization vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Depreciation & Amortization for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MGTXMeiraGTx Holdings plcLTM Mar 2026$12.82M USD+2.6%+13.6%16.1%
WVEWave Life Sciences Ltd.LTM Mar 2026$8.99M USD+4.0%-4.3%12.5%
PRMEPrime Medicine, Inc.LTM Mar 2026$7.48M USD+14.8%+34.3%185.3%
STOKStoke Therapeutics, Inc.LTM Mar 2026$3.54M USD+69.2%+4.6%11.0%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$2.88M USD-16.2%+25.6%6.4%
PRQRProQR Therapeutics N.V.LTM Mar 2026€2.72M EUR-0.9%+1.0%20.3%
SLNSilence Therapeutics plcLTM Mar 2026$577.79K USD—+4.5%62.7%
BNTCBenitec Biopharma Inc.LTM Mar 2026$475K USD+28.7%+0.3%—
RNAAtrium Therapeutics, Inc.FY2025$323K USD——1.7%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+4.0%+4.6%14.3%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.